Search Results - "Ignat'ev, G M"

Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years by Fel'dblyum, I. V., Novgorodova, S. D., Ignat'ev, G. M., Golodnova, S. O., Trukhin, V. P., Melnikov, S. Ya

“…This article presents the results of a simple, blind, randomized, placebo-controlled, single-center, prospective research of the reactogenicity, safety, and…”
Get full text

Specific humoral immunity after immunization with vaccine contained Leningrad-3 (L-3) mumps virus strain of different potency by Оtmshevskaya, E. V., Kulak, M. V., Bukin, E. K., Ignatev, G. M.

“…Aim. The persistence of the specific antibodies and the kinetics of the antibody neutralizing activity level and spectrum were studied in two groups of healthy…”
Get full text

Molecular-genetic study of the RA-27/3 strain used for production of rubella vaccine by Ignatev, G. M., Atrashevskaya, E. V., Suchanova, L. L., Sidorenko, E. S., Netesova, N. A.

“…Aim. In order to study rubella virus strain RA-27/3 genetic stability, used for the vaccines production, a molecular genetic study was conducted. Materials and…”
Get full text

REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF DOMESTIC FLU-M INACTIVATED SPLIT INFLUENZA VACCINE FOR THE IMMUNIZATION OF ADULTS AGED BETWEEN 18 AND 60 by Feldblyum, I. V., Subbotina, K. A., Novgorodova, S. D., Ignatev, G. M., Alyeva, M. Kh, Erofeeva, M. K., Orlovsky, V. G., Leneva, I. A., Melnikov, S. Ya, Kazakova, E. V., Nacharova, E. P., Trukhin, V. P.

“…Aim. The research was aimed at evaluating the reactogenicity, safety and immunogenicity of Flu-M inactivated split influenza vaccine. Materials and methods…”
Get full text

Cloning, expression, and purification of the nucleocapsid protein of SARS coronavirus by Netesova, N A, Belavin, P A, Seregina, E V, Ignat'ev, G M, Sandakhchiev, L S

“…(ProQuest: Abstract omitted; see image)[PUBLICATION ABSTRACT]…”
Get full text

Primary characterization of SARS coronavirus strain Frankfurt 1 by Agafonov, A P, Gus'kov, A A, Ternovoi, V A, Ryabchikova, E I, Durymanov, A G, Vinogradov, I V, Maksimov, N L, Ignat'ev, G M, Nechaeva, E A, Netesov, S V

Get full text

Development of a candidate polyvalent live vaccine against human immunodeficiency, hepatitis B, and orthopox viruses by Shchelkunov, S N, Nesterov, A E, Ryazankin, I A, Ignat'ev, G M, Sandakhchiev, L S

“…(ProQuest: Abstract omitted; see image)[PUBLICATION ABSTRACT]…”
Get full text

Construction of an artificial immunogen, a candidate DNA vaccine encoding multiple CTL epitopes of HIV-1 by Bazhan, S I, Belavin, P A, Seregin, S V, Danilyuk, N K, Babkina, I N, Karpenko, L I, Nekrasova, N A, Lebedev, L R, Agafonov, A P, Ignat'ev, G M, Il'ichev, A A, Sandakhchiev, L S

“…(ProQuest: Abstract omitted; see image)[PUBLICATION ABSTRACT]…”
Get full text

The Study in Animal Models of Local Action, Acute and Chronic Toxicity of Inactivated Influenza Vaccine Ultriks in Syringe by Kurskaya, O. G., Sharshov, K. A., Alekseev, A. Yu, Gulyaeva, M. A., Shestopalov, A. M., Shestopalova, L. V., Ignatev, G. M., Shkurupiy, V. A.

“…The evaluation of acute and chronic toxicity and local effect of the inactivated influenza vaccine Ultriks in animal models (guinea pigs, mice BALB/c) was…”
Get full text

A model of molecular constructions of a combined bivaccine by Lebedev, L R, Goncharova, E P, Sizov, A A, Bulychev, L E, Odegov, A M, Ignat'ev, G M, Ryzhikov, A B

“…(ProQuest: Abstract omitted; see image)[PUBLICATION ABSTRACT]…”
Get full text

Genetic and molecular principles for the selection of Pseudomonas and Staphylococcus therapeutic bacteriophages by Miroshnikov, K A, Kulikov, E E, Darbeeva, O S, Lysko, K A, Ignat'ev, G M

“…The content of empirically selected bacteriophage mixtures, produced by Microgen for the prevention and treatment of staphylococcal and pseudomonade…”
Get more information

Design of immunogens as components of a new generation of molecular vaccines by Loktev, V.B., Ilyichev, A.A., Eroshkin, A.M., Karpenko, L.I., Pokrovsky, A.G., Pereboev, A.V., Svyatchenko, V.A., Ignat'ev, G.M., Smolina, M.I., Melamed, N.V., Lebedeva, C.D., Sandakhchiev, L.S.

“…Three new approaches to design effective immunogens are considered. At first, we derived an expression vector from bacteriophage M13 allowing the exposure of…”
Get full text

Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine by Otrashevskaia, E V, Krasil'nikov, I V, Ignat'ev, G M

“…Postvaccination immunity was studied in the children and teenagers without a history of clinical mumps infection, who had been immunized with the Leningrad-3…”
Get more information

Comparative evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus by Otrashevskaia, E V, Bukin, E K, Otrashevskaia, A V, Ignat'ev, G M

“…Two enzyme immunoassays (ELISA) for mumps antibody detection using the Enzygnost (Germany) and Parotit-screen (Russia) were comparatively assayed using sera of…”
Get more information

Detection and antigenic characteristics of the recombinant nucleocapsid proteins of Lassa and Marburg viruses by Vladyko, A S, Scheslenok, E P, Fomina, E G, Semizhon, P A, Ignat'ev, G M, Shkolina, T V, Kras'ko, A G, Semenov, S F, Vinokurov, N V

“…Two plasmid vectors, which allow the recombinant polypeptides of Lassa and Marburg viruses to be expressed in prokaryotic cells E. coli strain BL21 (DE3), were…”
Get more information

Comparative evaluation of Leningrad-3 mumps vaccine virus neurovirulence in a neonatal rat model by Ignat'ev, G M, Otrashevskaia, E V, Rubin, S A

“…The neurovirulence and replication potential of several mumps virus strains, including Leningrad-3 mumps vaccine virus (FSUE SIC "Microgen", Russia) and wild…”
Get more information

Functional state of specific immunity in children and teenagers vaccinated against mumps by Otrashevskaia, E V, Bukin, E K, Krasil'nikov, I V, Ignat'ev, G M

“…The functional state of immunity was evaluated from the avidity index (AI) of specific antibodies (IgG) and the level and spectrum of their neutralizing…”
Get more information

Specific humoral immunity after single immunization with mumps vaccine: data of a 3-year follow-up by Otrashevskaia, A V, Bukin, E K, Krasil'nikov, I V, Ignat'ev, G M

“…The level and spectrum of humoral specific immunity were studied in 60 volunteers immunized with Russian mumps vaccine. Specific IgG levels were measured by…”
Get more information

Immunogenic and protective characteristics of recombinant Lassa virus NP protein by Ignat'ev, G M

“…Recombinant fragment of Lassa virus (strain Josiah) nucleocapsid protein (corresponding to amino acid residues 141 + 569) constructed by Dr. Jan ter Meulen…”
Get more information

Isolation and study of the immunobiological properties of the recombinant proteins of measles virus by Kulak, M V, Netesova, N A, Belavin, P A, Seregina, E V, Ignat'ev, G M

“…Recombinant proteins rN (nucleocapsid) and rH/Nh (hemagglutinin) of the measles virus strain NovO/96 of genotype A were obtained. The immunobiological…”
Get more information